apparel stock could be at risk if retailers do not adjust size allocation models quickly enough
GLP-1 medications may help improve key cardiovascular risk factors, such as cholesterol levels and abdominal fat
(Bifidobacterium lactis BS01, Bifidobacterium breve BR03, Lactobacillus acidophilus LA02, Lactobacillus plantarum LP09, Lactobacillus rhamnosus LR06, Lactobacillus casei LC03, Bifidobacterium bifidum BB01, Streptococcus thermophilus YO8, Lactobacillus plantarum LP01, Lactobacillus rhamnosus LR05, Lactobacillus rhamnosus GG, Bifidobacterium longum BL03, Lactobacillus reuteri LRE02, Lactobacillus salivarius subsp. salivarius CRL1328, Bifidobacterium lactis BA05)
To move the ACR cutpoint higher for people with diabetes would require evidence that the risk for future ESKD or future heart disease was essentially the same at an ACR of 3 mg/mmol as it is at 2 mg/mmol
Use of specific dietary patterns Several dietary practices and topics of public interest intersect with use of GLP-1s, including ketogenic diets, intermittent fasting, and ultra-processed foods